Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
5
×
life sciences
national blog main
san francisco blog main
5
×
biotech
national top stories
san francisco top stories
boston blog main
clinical trials
deals
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
akouos
auris health
biogen
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
intuitive surgical
johnson & johnson
roboticsai
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
alex azar
alex gorsky
allergan
alliance for aging research
What
plans
5
×
cash
deal
drug
fda
ipo
medical
medicines
acquiring
acquisitions
administration
affects
americans
angry
announced
anti
approved
auris
benefited
billion
bio
builds
buy
ceo
clearance
collabs
company
company’s
covid
crunch
daniel
date
despite
developer
developing
didn’t
end
fear
frequency
gilead
Language
unset
Current search:
plans
×
fda
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Johnson & Johnson to Buy Robotics Startup Auris Health for $3.4B
@xconomy.com
5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans